Stoke Therapeutics Inc. (STOK)
NASDAQ
Real-time Data
01:30 PM
Day's Range
31.1652 wk Range
18.00Overview - STOK - Stoke Therapeutics Inc.
Key Statistics
Valuation
Enterprise Value
1.86B
P/E (Trailing)
‪48.80‬
P/E (Forward)
‪-9.51‬
PEG Ratio
‪0.36‬
Price / Sales (TTM)
‪78.26‬
Price / Book
‪6.04‬
EV / EBITDA
‪-8.43‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-701.65%‬
Return on Assets
‪-35.86%‬
Return on Equity
‪-61.10%‬
Ownership
Shares Outstanding
62.40M
Float
49.21M
Short % of Shares Outstanding
‪25.45%‬
Held by Insiders
‪3.69%‬
Held by Institutions
‪123.62%‬
Price stats
Beta
‪1.22‬
50-Day Avg
‪30.96‬
200-Day Avg
‪31.65‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
14 analysts
Average price target
‪$ 46.46‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - STOK - Stoke Therapeutics Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- STOKNASDAQStoke Therapeutics Inc.2.08BMarket Cap+41.56%52-week change48.81P/E (Trailing)‪0.00%‬Profit Margin
- ARGXNASDAQargenx SE American Depositary Receipt63.39BMarket Cap+30.55%52-week change39.65P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals Inc32.12BMarket Cap-87.94%52-week change40.23P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE28.64BMarket Cap+7.89%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.52BMarket Cap+21.81%52-week change19.30P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma, Inc.15.71BMarket Cap+38.32%52-week change-21.28P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBiomarin Pharmaceutical Inc.12.79BMarket Cap+11.28%52-week change174.00P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - STOK - Stoke Therapeutics Inc.
About
Stoke Therapeutics Inc. is a biotechnology company focused on developing RNA-based medicines to treat the underlying causes of severe genetic diseases. It employs its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) platform, which uses antisense oligonucleotides to upregulate protein expression from…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
